Ignite Creation Date:
2025-12-25 @ 4:59 AM
Ignite Modification Date:
2026-03-01 @ 5:20 PM
Study NCT ID:
NCT00300118
Status:
COMPLETED
Last Update Posted:
2014-05-19
First Post:
2006-03-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Oral Budesonide vs. Oral Mesalazine in Active Crohn's Disease (CD)
Sponsor:
Dr. Falk Pharma GmbH
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
BUC-52/CDA
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None